Baxter International Inc

Healthcare · Medical Instruments & Supplies

24.20$ +3.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Baxter International Inc (BAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,960 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BAX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	2,558	2,645	2,475	2,605	2,707	2,774	2,677	2,842	2,761	2,841	2,638	2,834	2,851	3,039	2,802	2,718	2,972	3,181	2,946	3,098	3,226	3,514	3,707	3,594	3,609	3,887	3,513	3,707	2,599	3,885	2,490	2,694	2,699	2,753	2,625	2,810	2,835	2,974	2,701	2,960	11,470
Cost of Revenue	1,487	1,543	1,431	1,473	1,577	1,612	1,563	1,603	1,529	1,649	1,558	1,681	1,621	1,741	1,639	1,680	1,777	1,990	1,801	1,865	1,905	2,108	2,359	2,223	2,564	2,424	2,238	2,596	1,543	2,413	1,529	1,663	1,666	1,794	1,764	1,819	1,885	2,397	1,810	1,928	8,020
Gross Profit	1,071	1,102	1,044	1,132	1,130	1,162	1,114	1,239	1,232	1,192	1,080	1,153	1,230	1,298	1,163	1,038	1,195	1,191	1,145	1,233	1,321	1,406	1,348	1,371	1,045	1,463	1,275	1,111	1,056	1,472	961	1,031	1,033	959	861	991	950	577	891	1,032	3,450
Research & Development	159	157	127	155	150	182	140	174	166	175	129	166	144	156	146	117	123	135	128	139	129	138	150	148	151	155	164	165	133	172	120	130	129	211	140	134	118	126	139	129	512
Selling, General & Administrative	726	771	9.0	8.0	8.0	697	622	681	684	9.0	601	641	627	666	628	590	601	650	627	675	680	885	1,052	976	942	912	914	964	1,002	935	995	1,021	754	1,972	703	718	708	761	728	735	2,932
Total Operating Expenses	885	820	691	785	830	879	682	855	850	794	697	803	771	762	754	707	725	785	755	809	808	1,023	1,185	1,107	3,925	1,110	1,146	1,128	877	1,143	846	852	878	1,394	803	800	778	1,306	825	815	3,724
Operating Income	186	282	353	347	300	283	432	384	382	398	383	350	459	536	409	331	470	406	390	424	513	383	163	264	-2,880	353	129	-17	179	329	115	179	155	-435	58	191	172	-729	66	217	-274
Interest Expense	20	20	20	21	22	23	22	24	24	23	25	28	28	30	30	40	42	41	37	37	54	78	88	93	109	125	127	132	136	117	103	104	101	100	81	72	68	69	78	77	292
Pre-Tax Income	128	279	328	306	290	293	438	404	372	445	386	326	481	-223	378	289	415	210	351	392	451	283	94	219	-3,045	224	14	-183	64	238	46	117	69	-521	-3.0	133	121	-756	-6.0	158	-483
Income Tax Expense	1.0	39	55	42	42	354	49	61	-146	91	44	13	106	-204	45	42	56	39	51	91	-1.0	41	21	34	-54	39	-30	10	27	165	40	22	8.0	-33	-67	11	172	279	11	23	485
Net Income	130	243	272	265	251	-71	389	343	518	348	342	313	369	-23	332	246	356	168	298	298	450	238	71	252	-2,937	181	44	-141	2,508	245	37	-314	140	-512	126	91	-46	-1,128	-15	126	-1,063
EBITDA	352	500	542	511	496	515	652	623	595	659	603	547	646	16	607	531	666	464	605	651	711	606	562	655	-2,605	683	454	264	292	679	420	448	424	-176	325	462	426	-447	297	474	750

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings